Lolkje T W de Jong-van den Berg

Small proportions: what to report for confidence intervals?

Hilde Tobi, H. Tobi, L. de Jong-van den Berg, 2005, Pharmacoepidemiology and drug safety.

Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries.

Antje Neubert, Antonio Clavenna, Gerd Glaeske, 2011, British journal of clinical pharmacology.

First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.

Wilhelmina S Kerstjens-Frederikse, L. de Jong-van den Berg, C. Buys, 2009, Birth defects research. Part A, Clinical and molecular teratology.

Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system.

Hilde Tobi, Willemijn M. Meijer, H. Tobi, 2004, European journal of obstetrics, gynecology, and reproductive biology.

Consumer adverse drug reaction reporting: a new step in pharmacovigilance?

L. de Jong-van den Berg, Lolkje T W de Jong-van den Berg, Kees van Grootheest, 2003, Drug safety.

Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?

L. de Jong-van den Berg, B. Wilffert, Lolkje T W de Jong-van den Berg, 2010, Pharmacoepidemiology and drug safety.

Selection of controls in case-control studies on maternal medication use and risk of birth defects.

L. de Jong-van den Berg, Paul B van den Berg, Lolkje T W de Jong-van den Berg, 2007, Birth defects research. Part A, Clinical and molecular teratology.

The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges

Maarten J Postma, M. Postma, L. de Jong-van den Berg, 2013, Expert review of pharmacoeconomics & outcomes research.

Chlorpromazine Equivalents Versus Defined Daily Doses: How to Compare Antipsychotic Drug Doses?

L. de Jong-van den Berg, J. Brouwers, Lolkje T W de Jong-van den Berg, 2003, Journal of clinical psychopharmacology.

Teratogenic mechanisms of medical drugs.

Gerhard A Zielhuis, Nel Roeleveld, I. V. van Rooij, 2010, Human reproduction update.

Misdiagnosis and mistreatment of a common side-effect--angiotensin-converting enzyme inhibitor-induced cough.

S. Vegter, L. de Jong-van den Berg, Lolkje T W de Jong-van den Berg, 2010, British journal of clinical pharmacology.

Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists.

Willemijn M. Meijer, Wilhelmina S Kerstjens-Frederikse, L. de Jong-van den Berg, 2005, Reproductive toxicology.